Preclinical testing from a top preclinical Contract Research Organization in Kiev, Ukraine.
Our company is an independent CRO operating out of the United States that provides pre-clinical medicine services in top-notch, Good Laboratory Practices certified research laboratories in Kiev, UA. Our testing facilities are supported by the UNAMS and Ministry of Health and provide services for for-profit development of new medicine discoveries as part of their core mission. Our business was founded to bring the top-notch, low-cost services of these research sites to start-up bio-tech companies in the USA and Europe, thereby offering a smart option for advancing development programs rapidly and at much lower cost than other commercial Contract Research Organizations. We offer a wide range of preclinical CRO including medicine safety, chronic and acute toxicity, pharma screening, bioavailability, bio-equivalence , and extensive in vivo and in vitro screening for anticancer activity.
Our preclinical CRO is able to price pre-clinical services far below other Contract Research Organizations since we have a very low overhead in the U.S. and perform all trials in Ukraine where labor and laboratory costs are much lower. Our team in the USA consists only of the company principals who deal directly with clients; we don’t have any marketing costs other than our website, and no central offices, administrative staff or other overhead to inflate costs. We have much lower research conduct prices in Kiev due to much lower labor rates and are able to provide our best pricing for long-term and more intricate pre-clinical tests where labor is the greatest portion of the overall price. Because we utilize the same stable international providers for lab animals, reagents and lab materials as other Contract Research Organizations, we have no cost advantage on these materials and thus less overall cost savings for very short-term preclinical trials. But, regardless of your trial protocol and duration, our goal is to give our customers the greatest possible value for their investment.